Answers are grounded in this paper and cite their sources.
Background Schizophrenia is a leading cause of worldwide disability, but there remains considerable uncertainty regarding its underlying causes. We aimed to conduct a systematic Mendelian randomization (MR) analysis to identify risk factors for schizophrenia. Methods We first conducted an extensive literature review of meta-analyses and previous MR studies to pinpoint potential risk factors for schizophrenia. Out of 213 candidates, we selected 85 factors with available genetic instrumental variables for MR analyses. Summary-level data for schizophrenia (76,755 cases and 243,649 controls) were obtained from the Psychiatric Genomics Consortium. A comprehensive two-sample MR analysis was performed to assess the causal relationships. Results We identified robust causal associations between six risk factors and schizophrenia, which remained consistent across stringent sensitivity analyses. Specifically, genetically predicted bipolar disorder (OR IVW =1.49, 95% CI: 1.41 to 1.58, P = 1.53 × 10 − 44 ), major depressive disorder (OR IVW =1.57, 95% CI: 1.36 to 1.82, P = 1.31 × 10 − 9 ), worry sub-cluster (OR IVW =1.45, 95% CI: 1.08 to 1.95, P = 0.01), and the number of sexual partners (OR IVW =1.97, 95% CI: 1.62 to 2.39, P = 8.72 × 10 − 12 ) were significantly associated with an increased risk of schizophrenia. Conversely, higher cognitive abilities demonstrated robust protective effects, specifically intelligence quotient (OR IVW =0.82, 95% CI: 0.72 to 0.93, P = 1.91 × 10 − 3 ) and executive function (OR IVW =0.29, 95% CI: 0.19 to 0.45, P = 2.81 × 10 − 8 ). Crucially, reverse MR analyses revealed significant bidirectional effects across all six traits, demonstrating that genetic liability to schizophrenia also causally drives cognitive deterioration and exacerbates these psychiatric and behavioral vulnerabilities. Conclusion Our study evaluated 85 potential risk factors and established robust bidirectional causal associations between six core traits and schizophrenia. Ultimately, these findings emphasize that early cognitive remediation and proactive management of comorbid affective disorders are crucial to disrupt the mutually reinforcing cycle of schizophrenia progression. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: